| European Case Law Identifier: | ECLI:EP:BA:2004:T027604.20040624 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 24 June 2004 | ||||||||
| Case number: | T 0276/04 | ||||||||
| Application number: | 95921454.5 | ||||||||
| IPC class: | C12N 15/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Fibroblast growth factor-14 | ||||||||
| Applicant name: | Human Genome Sciences, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Decision reasoned in the sense of Rule 68(2) EPC (no) Substantial procedural violation (yes) Reimbursement of appeal fee (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t040276eu1.html
Date retrieved: 17 May 2021